France’s Mayoly Spindler Set To Acquire Ipsen’s Consumer Business

14 Feb 2022

Mayoly Spindler is stepping up its presence in the self-care market with the acquisition of Ipsen's Consumer Healthcare business, which has been under strategic review for the past year.

MT1809_Hand Shake_529519042_1200.jpg — • Source: Shuttestock

Laboratoires Mayoly Spindler is taking a significant step towards its goal of becoming a top-10 OTC player in Europe with the acquisition of Ipsen’s Consumer Healthcare business.

Paris, France-based Ipsen has entered into exclusive negotiations with privately held Mayoly Spindler to sell the Consumer Healthcare operation in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Prestige Consumer Starting Clear Eyes Production With No Contract Partner ‘Out There To Tap Into’

09 Aug 2025

• By Malcolm Spicer

PCH lowers full-year guidance even after reaching $100m deal to acquire Canadian sterile ophthalmic manufacturer for its Clears Eyes line troubled by supply slumps for several years. Its $47.5m reported net sales for April-June period were down 6% from a year ago.

Navamedic To Market OTC Naloxone In Norway Following Switch

21 Jul 2025

• By Tom Gallen

Navamedic adds Ventizolve to its portfolio shortly after Norway switched the opioid overdose reversal drug from Rx to OTC.

Reckitt Strikes Deal To Sell Essential Home Unit To Focus On CHC, Hygiene

18 Jul 2025

• By Tom Gallen

Advent International is poised to take control of Reckitt's Essential Home business, but the UK-based firm will retain a 30% stake.

Perrigo Implements Streamlining Plan With Sale Of Dermacosmetics

14 Jul 2025

• By Tom Gallen

Perrigo stands to gain up to €327m with sale of brands such as ACO and Emolium to KKR.

Repeat Buyers Passing 50% Key For Opill Sales Leading Perrigo’s Women’s Health Growth

06 Aug 2025

• By Malcolm Spicer

“We continue to grow the brand. It was slower than initially anticipated or forecasted in basis, but I'm pleased with how it's developing,” says CEO Patrick Lockwood-Taylor of Opill performance.